/en/labbook/chemistry-immunochemistry/2664-snibe-maglumi-sars-cov-2-s-rbd-igg-ii-clia.html Snibe - Maglumi SARS-CoV-2 S-RBD IgG II (CLIA) • healthcare-in-europe.com

Chemistry & immunochemistry

More Offers

Snibe Diagnostic

Snibe - Maglumi SARS-CoV-2 S-RBD IgG II (CLIA)

Highlights:
New generation, wider range, better assessment

  • The fully automated quantitative serology test to detect IgG antibodies against S-RBD
  • Broad linear range from 0.375-1000 AU/mL
  • Assist in the diagnosis of the COVID-19
  • Assess the immune response to the COVID-19 after the natural infection and vaccination
  • Low sample volume of 10 μL
  • Diverse package specifications (50, and 100 tests per kit) to cover the testing needs of small labs to big hospitals

Snibe Diagnostic

No.23, Jinxiu East Road
518122 Shenzhen
China

Related products

Snibe – Molecision MP-96

Extraction

Snibe – Molecision MP-96

Snibe Diagnostic
Snibe – Molecision MP-32

Extraction

Snibe – Molecision MP-32

Snibe Diagnostic
Snibe - Maglumi X3

Immunoassays

Snibe - Maglumi X3

Snibe Diagnostic
Snibe – Maglumi X8

Immunoassays

Snibe – Maglumi X8

Snibe Diagnostic
Snibe – Molecision SARS-CoV-2 RT-PCR Assay

Infectious Disease

Snibe – Molecision SARS-CoV-2 RT-PCR Assay

Snibe Diagnostic
Snibe - Biossays E6

Clinical Chemistry

Snibe - Biossays E6

Snibe Diagnostic
Subscribe to Newsletter